← Open Payments lookup

DAVID DONAHUE: Open Payments

NPI 1871589028 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,290 in 106 payments from 19 companies in 2025. Trend: 2023 $1,102 · 2024 $1,845 · 2025 $2,290

Food & beverage: $2,290
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$400
Alkermes, Inc.10$225
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$208
ABBVIE INC.11$203
Otsuka America Pharmaceutical, Inc.11$175
Lundbeck LLC7$162
Noven Therapeutics, LLC8$137
Axsome Therapeutics, Inc.5$125
Vanda Pharmaceuticals Inc.5$120
Takeda Pharmaceuticals U.S.A., Inc.5$116

Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, ARISTADA, Xelstrym, Auvelity, TRINTELLIX.

Industry payments across FL — which companies pay providers there.